Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JANUARY 24, 2009 FBO #2616
SOLICITATION NOTICE

99 -- Foot and Mouth Disease (FMD) and Rift Valley Fever (RVF) Vaccine Production

Notice Date
1/22/2009
 
Notice Type
Presolicitation
 
NAICS
325414 — Biological Product (except Diagnostic) Manufacturing
 
Contracting Office
Office of the Chief Procurement Officer, Washington, District of Columbia, 20528, United States
 
ZIP Code
20528
 
Solicitation Number
RSCB-09-00NNN
 
Archive Date
3/24/2009
 
Point of Contact
Timothy L Davis,, Phone: 202-254-5676, Jennifer Fagan, Phone: 202-254-6665
 
E-Mail Address
timothy.davis@hq.dhs.gov, jennifer.fagan@associates.dhs.gov
 
Small Business Set-Aside
N/A
 
Description
The Department of Homeland Security, Science and Technology Directorate, intends to award one contract for FMD and RVF vaccine production using FAR Part 15 RFP procedures. A written solicitation will be issued. This will be a full and open competition, and DHS shall consider all proposals submitted by responsible sources. The anticipated award date is August, 2009. Description of Work: Pursuant to Homeland Security Presidential Directive-9 (HSPD-9), the Secretary of Homeland Security is responsible for coordinating the overall national effort to enhance the protection of the critical infrastructure and key resources of the United States. This includes the defense of agriculture and food. Under HSPD-9, DHS is tasked with accelerating and enhancing the development of countermeasures – including vaccines – for Foreign Animal Diseases (FADs). HSPD-9 also recognized the need for a federal stockpile and mandated the creation of the National Veterinary Stockpile. This effort is to support the development and production of Foot and Mouth Disease (FMD) and Rift Valley Fever (RVF) vaccines for the National Veterinary Stockpile. Specifically, the Contractor will be required to: (a) Produce master seeds (MS) for replication, deficient, human adenovirus serotype 5 vectored FMD (AdFMD) vaccines master seed cell lines (MSC) for FMD and RVF vaccines; (b) Produce pre-licensing serials (PLS) for AdFMD vaccines; (c) Develop AdFMD vaccine process improvement and yield optimization methods to decrease cost of goods of AdFMD vaccines; (d) Develop in vitro relative potency release assays for AdFMD vaccines; (e) Provide regulatory services, including management of clinical studies, to enable submission of a CVB product license applications for several AdFMD vaccine; and (f) Produce MS and master seed cell line (MSC) for rationally designed marker RVF vaccines. Only entities that have or are capable of obtaining a U.S. Veterinary Biologics Establishment License (see (CFR 102.3(a)) will be eligible for the award of this contract. Performance under this contract will occur at the Contractor’s place of business. Deliveries, including the master seeds, cell lines, and proof of regulatory compliance, are to be shipped to a TBD DHS address. It is anticipated that this will be a 4 year effort, with a 1 year base period and 3 one year option periods.
 
Web Link
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=2854129f58149de46eb50d65f6e80db8&tab=core&_cview=1)
 
Place of Performance
Address: Contractor's Facility - TBD, United States
 
Record
SN01736454-W 20090124/090122220058-2854129f58149de46eb50d65f6e80db8 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.